Literature DB >> 2433642

In situ analysis of neostriatal RNA and chromatin in Alzheimer's disease.

J A Doebler, W R Markesbery, A Anthony, R E Rhoads.   

Abstract

Scanning-integrating microdensitometry of azure B-RNA- and Feulgen-Schiff-stained tissue sections was used to measure neostriatal neuronal RNA levels and susceptibility of neuronal and oligodendrocyte chromatin to acid hydrolysis in Alzheimer's disease (AD) patients and controls. AD was associated with neuronal RNA depletion (17 to 23%) in both caudate nucleus and putamen. While neuronal chromatin was found to be more acid-labile than that of the oligodendrocytes, there were no differences in either cell type between AD and controls. These data support the existence of a macromolecular disturbance (RNA loss) occurring within neostriatal neurons, perhaps related to the extrapyramidal dysfunction of AD, but fail to demonstrate that an alteration in chromatin is responsible for this effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433642     DOI: 10.1212/wnl.37.2.309

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Astrocyte RNA in relation to neuronal RNA depletion in Alzheimer's disease.

Authors:  J A Doebler; W R Markesbery; A Anthony; S W Scheff; R E Rhoads
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

2.  Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease.

Authors:  W S Griffin; C Ling; C L White; M Morrison-Bogorad
Journal:  Alzheimer Dis Assoc Disord       Date:  1990       Impact factor: 2.703

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.